Literature DB >> 11458389

TGF-beta1 perturbs vascular development and inhibits epithelial differentiation in fetal lung in vivo.

X Zeng1, M Gray, M T Stahlman, J A Whitsett.   

Abstract

Members of the transforming growth factor beta (TGF-beta) family of polypeptides have been implicated in morphogenesis and differentiation in numerous tissues, including the lung. In order to further define effects of TGF-beta signaling in lung morphogenesis, a constitutively active form of TGF-beta1 was expressed in respiratory epithelial cells of the fetal mouse lung in vivo. Expression of TGF-beta1 arrested lung morphogenesis in the pseudoglandular stage of development, inhibiting synthesis of differentiation-dependent proteins, SP-B, SP-C, and CCSP, and maintaining embryonic patterns of staining for thyroid transcription factor-1 (TTF-1) and hepatocyte nuclear factor-3beta (HNF-3beta). The pulmonary mesenchyme was thickened and vascular density was increased by TGF-beta1. TGF-beta1 decreased expression of vascular endothelial growth factor-A (VEGF-A) mRNA and protein, and the abundance of Flk-1 mRNA in the lung mesenchyme. Distribution of platelet-endothelial cell adhesion molecule (PECAM)-1, a marker of pulmonary blood vessels, was altered, and ultrastructural studies demonstrated that TGF-beta1 inhibited vascular development in the fetal lung. TGF-beta1 perturbed both epithelial cell differentiation and formation of the pulmonary vasculature, supporting the concept that precise control of signaling via the TGF-beta receptor pathway is critical for normal lung morphogenesis. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11458389     DOI: 10.1002/dvdy.1140

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  21 in total

Review 1.  Airway and blood vessel interaction during lung development.

Authors:  Alison A Hislop
Journal:  J Anat       Date:  2002-10       Impact factor: 2.610

Review 2.  Disorders of lung matrix remodeling.

Authors:  Harold A Chapman
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 3.  Lung organogenesis.

Authors:  David Warburton; Ahmed El-Hashash; Gianni Carraro; Caterina Tiozzo; Frederic Sala; Orquidea Rogers; Stijn De Langhe; Paul J Kemp; Daniela Riccardi; John Torday; Saverio Bellusci; Wei Shi; Sharon R Lubkin; Edwin Jesudason
Journal:  Curr Top Dev Biol       Date:  2010       Impact factor: 4.897

Review 4.  Collectins and cationic antimicrobial peptides of the respiratory epithelia.

Authors:  B Grubor; D K Meyerholz; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

5.  Role played by Prx1-dependent extracellular matrix properties in vascular smooth muscle development in embryonic lungs.

Authors:  Kaori Ihida-Stansbury; Juliana Ames; Mithil Chokshi; Norman Aiad; Sonali Sanyal; Kimihito C Kawabata; Ilya Levental; Harini G Sundararaghavan; Jason A Burdick; Paul Janmey; Kohei Miyazono; Rebecca G Wells; Peter L Jones
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

6.  Lung alveolar septation defects in Ltbp-3-null mice.

Authors:  Cristina Colarossi; Yan Chen; Hiroto Obata; Vladimir Jurukovski; Laura Fontana; Branka Dabovic; Daniel B Rifkin
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

7.  ALK-5 mediates endogenous and TGF-beta1-induced expression of connective tissue growth factor in embryonic lung.

Authors:  Shu Wu; Jinghong Peng; Matthew R Duncan; Kalyani Kasisomayajula; Gary Grotendorst; Eduardo Bancalari
Journal:  Am J Respir Cell Mol Biol       Date:  2006-12-29       Impact factor: 6.914

8.  Mesodermal deletion of transforming growth factor-beta receptor II disrupts lung epithelial morphogenesis: cross-talk between TGF-beta and Sonic hedgehog pathways.

Authors:  Min Li; Changgong Li; Yi-hsin Liu; Yiming Xing; Lingyan Hu; Zea Borok; Kenny Y-C Kwong; Parviz Minoo
Journal:  J Biol Chem       Date:  2008-11-06       Impact factor: 5.157

Review 9.  Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease.

Authors:  Wei Shi; Felicia Chen; Wellington V Cardoso
Journal:  Proc Am Thorac Soc       Date:  2009-12-01

10.  VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.

Authors:  Laszlo Farkas; Daniela Farkas; Kjetil Ask; Antje Möller; Jack Gauldie; Peter Margetts; Mark Inman; Martin Kolb
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.